Chest, Vol 102, 506-509, Copyright © 1992 by American College of Chest Physicians

ARTICLES

Variable severity of pulmonary disease in adults with identical cystic fibrosis mutations

W Burke, ML Aitken, SH Chen and CR Scott
Department of Medicine, University of Washington, Seattle 98195.

Adults with CF followed in a university center were assessed for the presence of the most common CF gene mutation, delta-F508. Excluding one member of a sibling pair, 29 of 55 subjects had two copies of delta- F508 (homozygotes), 23 had one copy of delta-F508 with the other CF mutation not identified (complex heterozygotes) and three were lacking delta-F508. A wide range of clinical severity was seen among individuals carrying two copies of the delta-F508 gene, who are genetically identical at the CF gene locus. The number of individuals diagnosed with CF as adults was significantly lower in the homozygote group (1 of 29) as compared with the heterozygote group (7 of 24). No differences were detected between groups in pulmonary function, non- pulmonary complications or overall clinical severity. These results suggest that environmental or background genetic factors contribute significantly to the variability in pulmonary and other complications seen among individuals with CF.

This article has been cited by other articles:

				E. F. McKone, C. H. Goss, and M. L. Aitken CFTR Genotype as a Predictor of Prognosis in Cystic Fibrosis. Chest, November 1, 2006; 130(5): 1441 - 1447. [Abstract] [Full Text] [PDF]

				J. Laki, I. Laki, K. Nemeth, R. Ujhelyi, O. Bede, E. Endreffy, K. Bolbas, K. Gyurkovits, E. Csiszer, E. Solyom, et al. The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis Int. Immunol., November 1, 2006; 18(11): 1585 - 1590. [Abstract] [Full Text] [PDF]

				D. M. Rodman, J. M. Polis, S. L. Heltshe, M. K. Sontag, C. Chacon, R. V. Rodman, S. J. Brayshaw, G. A. Huitt, M. D. Iseman, M. T. Saavedra, et al. Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 621 - 626. [Abstract] [Full Text] [PDF]

				W. Burke Genomics as a Probe for Disease Biology N. Engl. J. Med., September 4, 2003; 349(10): 969 - 974. [Full Text] [PDF]

				P. D. Arkwright, V. Pravica, P. J. Geraghty, M. Super, A. K. Webb, M. Schwarz, and I. V. Hutchinson End-Organ Dysfunction in Cystic Fibrosis: Association with Angiotensin I Converting Enzyme and Cytokine Gene Polymorphisms Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 384 - 389. [Abstract] [Full Text] [PDF]

				Y. Loubieres, D. Grenet, B. Simon-Bouy, J. Medioni, P. Landais, C. Ferec, and M. Stern Association Between Genetically Determined Pancreatic Status and Lung Disease in Adult Cystic Fibrosis Patients Chest, January 1, 2002; 121(1): 73 - 80. [Abstract] [Full Text] [PDF]

				K.-H. Gan, H. J. Veeze, A. van den Ouweland, D. Halley, H. Scheffer, A. van der Hout, S. E. Overbeek, J. C. de Jongste, W. Bakker, and H. Heijerman A Cystic Fibrosis Mutation Associated with Mild Lung Disease N. Engl. J. Med., July 13, 1995; 333(2): 95 - 99. [Abstract] [Full Text] [PDF]